オハイオにおける消化器がんの臨床試験
オハイオ内の拠点で、消化器がんに関する15件の研究が参加者を募集しています。
オハイオ内の都市
公式研究テキスト（英語）
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- TriHealth Cancer Institute-Westside, Cincinnati
- 他1件
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07283939Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Dayton Veterans Affairs Medical Center, Dayton
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07215624A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Cleveland Clinic - Oncology Department, Cleveland
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06760819Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Oncology Hematology Care - Eastgate, Cincinnati
- University Hospitals Cleveland Medical Center, Cleveland
- Oncology Hematology Care Clinical Trials, LLC, Fairfield
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07222800DESTINY-PANTUMOUR04
- Research Site, Canton
- Research Site, Maumee
被験者募集中観察研究
18歳〜130歳 · 全性別 · 2026/09/25更新 · NCT07124000A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
- GSK Investigational Site, Canton
- GSK Investigational Site, Columbus
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07218926Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- University of Cincinnati Medical Center, Cincinnati
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06445062EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
被験者募集中
18歳以上 · 全性別 · 2026/09/15更新 · NCT06263088A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
- University of Cincinnati Cancer Center, Cincinnati
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/27更新 · NCT07544589A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- The Ohio State University Comprehensive Cancer Center, Columbus
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/11更新 · NCT05592626Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- The Christ Hospital, Cincinnati
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/03更新 · NCT06040541A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- The Ohio State University Wexner Medical Center, Columbus
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/05/27更新 · NCT03093116A Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors
- USA03-0, Cincinnati
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/22更新 · NCT07263594Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Christ Hospital Cancer Center, Cincinnati
- Taylor Cancer Research Center, Maumee
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/15更新 · NCT05379985Feasibility Study of CBCT for IGRT in Cancer Patients
- James Outpatient Center, Columbus
- Ohio State University, Brain and Spine Hospital, Columbus
- The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus
- 他1件
被験者募集中
18歳以上 · 全性別 · 2026/03/13更新 · NCT06681233ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。